Last reviewed · How we verify
NCT06356909: SUPREMEneo
Study of PREMEdication Before Laryngoscopy in Neonates in France
trial testing Survey of sedo-analgesia practices before laryngoscopy in Neonatal Respiratory Distress in 741 participants. Completed in 7 April 2024.
7 April 2024
Quick facts
| Lead sponsor | Centre Hospitalier Intercommunal Creteil |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 741 |
| Start date | 11 March 2024 |
| Primary completion | 7 April 2024 |
| Estimated completion | 7 April 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Survey of sedo-analgesia practices before laryngoscopy
Conditions studied
- Neonatal Respiratory Distress — all drugs for Neonatal Respiratory Distress →
Sponsor
Centre Hospitalier Intercommunal Creteil
Who can join
Adults 20 Weeks to 44 Weeks, any sex, with Neonatal Respiratory Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a national prospective survey on practices of premedication before laryngoscopy in neonates. The survey will evaluate adequation to the French best practice guidelines to improve their dissemination and to identify current practices of premedication before laryngoscopy in neonates in French units (agents, dosing, efficacy, safety)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06356909
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Respiratory Distress
Currently open trials in the same condition.
- NCT06572033 — Transference of Established Simulated Skills (TEST) Trial · active not recruiting
Other Centre Hospitalier Intercommunal Creteil trials
Trials by the same sponsor.
- NCT07493785 — Dexmedetomidine for Invasive Ventilation In the NEOnate · Phase 2, PHASE3 · not yet recruiting
- NCT07513051 — DIaphragmatic Swing According to Cpap Flow Output in NEOnates (DISCONEO) · NA · not yet recruiting
- NCT07455942 — Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer · not yet recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
- NCT06339450 — Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06356909 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Intercommunal Creteil
- Last refreshed: 27 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06356909.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing